ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

$2-A-Pack Cigarette Tax A “Significant Deterrent,” NCAB Resolution Says

October 8, 1993

ACS Survey Finds Need for Cancer Education Among Hispanic Americans

August 2, 1985

In Brief: House, Senate Differ On NCI Positions; Upton Says Viral Oncology research Will Be Continued

August 12, 1977

FDA Forms Office of Combination Products;

January 10, 2003

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003